Medical College of Wisconsin
CTSIResearch InformaticsREDCap

CURRICULUM VITAE

Ashima Singh PhD
Assistant Professor
Department of Pediatrics
Division of Pediatrics Hematology Oncology Blood and Marrow Transplant

OFFICE ADDRESS:
999 N. 92nd Street
Milwaukee, WI 53226

EDUCATION:
2003 - 2007 Bachelors of Technology (B.Tech), Biotechnology, Uttar Pradesh Technical University, India
2007 - 2009 Master of Science (MS), Biomedical Informatics, University of Medicine and Dentistry of New Jersey (now Rutgers)
2010 - 2015 Doctor of Philosophy (PhD), Epidemiology, Pitt Public Health

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
2009 - 2010 Health Economics and Outcomes Research Fellow, Rutgers University/ Ortho-McNeil-Janssen Pharmaceuticals
2015 - Present May 2016 Senior Statistician, Department of Epidemiology, University of Pittsburgh
2016 - Present Dec 2019 Research Scientist, Pediatrics, Medical College of Wisconsin, Division of Hematology/Oncology

FACULTY APPOINTMENTS:
01/01/2020 - 06/2021 Instructor, Pediatrics, Hematology/Oncology/BMT, Medical College of Wisconsin
07/2021 - Present Assistant Professor, Pediatrics, Division of Hematology/Oncology, Medical College of Wisconsin

AWARDS AND HONORS:
2009 - Present Certificate of Excellence for Academic Achievements, University of Medicine and Dentistry of New Jersey, May 2009.
2015 - Present Second Prize, Poster Fellows Research Day, American Heart Association, January
2017 - 2018 Outstanding Medical School Teacher Pin
2017 - Present Travel Award, Department of Pediatrics and Children's Research Institute, Children's Hospital of Wisconsin for Pediatric Academic Societies Meeting, May 2017.
2018 - 2019 Outstanding Medical School Teacher Pin
2018 - 2019 Outstanding Graduate Student Educator Pin
2019 - 2020 Outstanding Medical School Teacher Pin, Medical College of Wisconsin
2023 - 2024 MCW Collaborative for Healthcare Delivery Science Scholarship, Medical College of Wisconsin

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2011 - 2012 Student Public Health Epidemic Response Effort (SPHERE), University of Pittsburgh (Secretary.)
2012 - 2013 Society of Women Engineers (SWE), New Jersey Institute of Technology (Mentor)
2016 - 2017 American College of Epidemiology (Fellow)
2019 - Present American Society of Hematology (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
Clinical Epidemiology
ClinicoEconomics and Outcomes Research
Comparative Effectiveness Research
Patient Preference and Adherence
Blood Advances
British Journal of Hematology
Pain Medicine
BMC Health Services Research
Blood VTH
BMC Pediatrics
Pediatric Hematology/Oncology

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2021 - 05/2024 Sickle Cell Disease Data Hub informatics leadership group, American Society of Hematology
2021 Technical Advisor Group, Sickle Cell Disease Data Hub, American Society of Hematology
06/2024 - Present Committee Member, SCD Data Quality Committee, ASH Research Collaborative
08/2024 - Present Committee Member, SCD Scientific Research Project Team, ASH Research Collaborative
03/2025 - Present Steering Committee, ASH Research Collaborative Real-World Evidence Consortium (ASH RWE-C)

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Sickle Cell Data Collection Program in Wisconsin
Source:
Centers for Disease Control and Prevention
Role & Effort:
Principal Investigator
Dates:
10/2020 - 10/2023
  
Title:
Investigating the role of the microbiome and inflammation in acute and chronic pain in patients with sickle cell disease
Source:
NIH/NHLBI 1R01HL142657-01
Role & Effort:
Co-Investigator
Dates:
06/01/2021 - 08/31/2023
  
Title:
The inflammatory index as a biomarker for pain in patients with sickle cell disease
Source:
NIH/NINDS 1R61NS114954-01
Role & Effort:
Co-Investigator
Dates:
06/01/2021 - 07/31/2022
  
Title:
Surveillance Epidemiology of Coronavirus (COVID-19) Under Research Exclusion in Sickle Cell Disease (SECURE-SCD)
Source:
Doris Duke Charitable Foundation
Role & Effort:
Principal Investigator
PI:
Dr. Ashima Singh
Dates:
06/01/2021 - 06/01/2023
  
Title:
Sickle Cell Disease Treatment Demonstration Project. Sickle Treatment and Outcomes Research in the Midwest (STORM)
Source:
HRSA
Role & Effort:
Site Co-Investigator
Dates:
09/01/2021 - 08/31/2026
  
Prior
Non-Peer Review
Title:
Learning Health System for Sickle Cell Disease (Panepinto)
Source:
Greater Plains Collaborative, PCORnet
Role & Effort:
Co-investigator
Dates:
09/2017 - 09/2018
  
Title:
Sickle Cell Data Collection Program in Wisconsin
Source:
Centers for Disease Control and Prevention
Role & Effort:
Principal Investigator
PI:
Dr. Ashima Singh
Dates:
10/2020 - 09/2023
  
Title:
Leveraging electronic health record data to improve our understanding of sickle cell disease
Source:
Children’s Research Institute
Role & Effort:
Principal Investigator
PI:
Dr. Ashima Singh
Dates:
04/27/2021 - 12/31/2021
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
International
Singh A Bartsch SM Muder RR Lee BY, Economic Value of Using Antimicrobial Coated Sutures, Poster presentation at International Society for Pharmacoeconomics and Outcomes Research, Montreal Canada, 06/2014
Singh A Dasgupta M Simpson PM Panepinto JA, Use of the PROMIS new physical health domains and the asthma impact scale in children with an acute asthma exacerbation, Poster presentation at International Society for Quality of Life Research, Dublin Ireland, 10/2018
Singh A Dasgupta M Simpson PM Panepinto JA, Validation of new Patient Reported Outcome Measurement Information System (PROMIS) measures in children with sickle cell disease, Poster presentation at International Society for Quality of Life Research, Dublin Ireland, 10/2018
Singh A, COVID-19 in children with sickle cell disease., Invited talk at Brazilian Congress of Hematology, Hemotherapy and Cellular Therapy, Virtual, 11/04/2020
COVID-19 outcomes among individuals with sickle cell disease, International Association of Sickle Cell Nurses and Allied Professionals, 04/21/2022
STORM ECHO presentation A Perspective on the SECURE-SCD – An international Sickle Cell Disease and COVID-19 Registry, 05/2023
Panelist for the COVID-19 and sickle cell disease session, the Symposium and Launch of the Lancet Commission on Sickle Cell Disease, Muhimbili University of Health And Allied Sciences (Muhas)Dar-Es-Salaam, Tanzania, 07/2023
 
National
Singh A Brooks MM Schaff HV Hlatky M Frye RL Sako EY, On-Pump vs off-pump coronary artery bypass graft surgery among patients with type 2 diabetes, Poster presentation at Fellows Research Day American Heart Association, Pittsburgh PA, 01/2015
Singh A Panepinto JA, Using electronic health records (EHRs) to facilitate a rapid-learning health system for children with sickle cell disease (SCD), Poster Presentation at Pediatric Academic Society Meeting, San Francisco CA, 05/2017
Singh A Yan K Brandow A Panepinto JA, Longitudinal Trend of Emergency Department Reliance for Pain among Sickle Cell Disease Patients in Wisconsin, Oral Presentation. American Society of Hematology, Atlanta GA, 12/2017
Singh A Panepinto JA, Clinical Meaning of Promis Pain Interference and Pain Behavior Measures for Children with Sickle Cell Disease, Oral Presentation 60th American Society of Hematology, 2018
Singh A Dasgupta M Simpson PM Panepinto JA,, Poster presentation Validation of Patient Reported Outcome Measurement Information System (PROMIS) measures for children with type 1 diabetes, International Society for Quality of Life Research, San Diego CA, 2019
Singh A Brandow A Panepinto JA, COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait, Oral Presentation at American Society of Hematology, Virtual, 12/2020
Mucalo L Brandow AM Mason SF Singh A Taylor BW Woods KJ Yusuf F, Panepinto JA, Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection, Oral Presentation and Poster at American Society of Hematology, 12/2020
COVID-19 outcomes among individuals with sickle cell disease, Tracking California SCDC Webinar, 05/12/2022
Dr. Melissa Azul, Dr. Ashima Singh, Family Medicine Residency Curriculum Didactics on Sickle Cell Disease, 05/2024
Ashima Singh, David C. Brousseau, Mahua Dasgupta, Amanda Brandow, Epidemiology and the Concentration of Acute Care for Individuals with Sickle Cell Disease in the State of Wisconsin, Sickle Cell Data Collection Summit, Atlanta, GA, 10/2024
Jessy J. Rico, Ashima Singh, Raising Sickle Cell Disease Awareness Through Communication in Wisconsin., Sickle Cell Data Collection Summit, Atlanta, GA, 10/2024
Challenges in Data Quality: Where EHR Data Acquisition Approaches and Highly Curated Datasets Intersect. ASH Research Collaborative Data Hub Sickle Cell Disease Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation., American Society of Hematology Meeting, 12/2024
Singh A Bartsch SM Avery TR Potter PA James E Huang SS Lee BY, Readmissions within Thirty Days of Discharge to Any Hospital in Orange County California, Poster Presentation at Deans Day, University of Pittsburgh
 
Local
Singh A Panepinto JA, Real-time electronic registry improves care for children with sickle cell disease
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
National
Singh A, Dasgupta M, Retherford D, Baker M, Brandow AM, Surveillance for sickle cell disease in Wisconsin, Oral Presentation at Sickle Cell Disease Association of America (SCDAA) Annual Convention, 10/2021
Mucalo L, Brandow MA, Singh A, Opioid-Related Mortality for Individuals with Sickle Cell Disease Remains Low with No Significant Increase during 2013-2019, Oral Presentation at American Society of Hematology, 12/2021
Singh A, Brandow AM, Shet AS, Venous Thromboembolism Post-COVID-19 Among Individuals with Sickle Cell Disease, Poster Presentation at American Society of Hematology, 12/2021
Mucalo L, Brandow AM, Singh A, A Perspective on the Sickle Cell Disease International COVID Registry, Oral Presentation at Sickle Cell Disease Association of America, 10/2022
Singh A, Dasgupta M, Brandow AM, and Brousseau DC, Acute Care Utilization Among Individuals with Sickle Cell Disease and Related Cardiopulmonary and Renal Complications, Poster presentation at American Society of Hematology, 12/2022
Mucalo L, Jia S, Roethle MF, Singh A, Brousseau DC, Panepinto JA, Hessner MJ, Brandow AM, Identification of hub genes associated with acute pain episodes in individuals with sickle cell disease, Poster presentation at US Association for the Study of Pain Annual Scientific Meeting, Durham, NC, 04/2023
Mariam Kayle, Audrey Blewer, Wei Pan, Jennifer A Rothman, Carri Polick, Joshua Rivenbark, Elliott Fisher, John J Strouse, Shelby Weeks, Jay Desai, Angie Snyder, Mei Zhou, Ankit Sutaria, Sophia Horiuchi, Jhaqueline Valle, Marci K Sontag, Joshua I Miller, Ashima Singh, Mahua Dasgupta, Issac A Janson, Najibah Galadanci, Ayme Miles, Shamaree J Cromartie, Sarah L Reeves, Krista Latta, William O Cooper, Allison Plaxco, Matthew P Smeltzer, Sickle Cell Disease Births and Social Vulnerability (2016-2020): A Report from the Sickle Cell Data Collection Program, Poster Presentation at the American Society of Hematology, 12/2023
Lana Mucalo, MD*, Shuang Jia, Singh A, PhD, Mark Roethle, Janelle Highland, MA, Dawn Retherford, Jessica J. Rico, Nicole Steiner, Martin Hessner, PhD and Amanda M. Brandow, DO, MS, Gene Transcriptional Profiles of Individuals with HbS Trait Are Different from Individuals without HbS Trait, American Society of Hematology Annual Meeting, 12/2023
Singh A, PhD*, Mahua Dasgupta, MS, Julie A. Panepinto, MD, MSPH and Amanda M. Brandow,DO, MS, Longitudinal Trends in Physical Functioning Patient-Reported Outcome Domains for Children with Sickle Cell Disease, American Society of Hematology Annual Meeting, 12/2023
Singh A, PhD*, David C. Brousseau, MD, MS, Kristen Osinski and Amanda M. Brandow, DO, MS, Timeliness of Opioid Administration for Pain in the Emergency Department for Adults with Sickle Cell Disease, American Society of Hematology Annual Meeting, 12/2023
Lana Mucalo, MD*, Singh A, PhD, Shuang Jia, Mark Roethle, Julie A. Panepinto, MD, MSPH,David C. Brousseau, MD, MS, Martin Hessner, PhD, and Amanda M. Brandow, DO, MS, Observed Variability in Gene Expression in Individuals with Sickle Cell Disease during Baseline Health and Acute Pain, American Society of Hematology Annual Meeting, 12/2023
Lana Mucalo, MD*, Shuang Jia, Singh A, PhD, Mark Roethle, Janelle Highland, MA, Dawn Retherford, Jessica J. Rico, Nicole Steiner, Martin Hessner, PhD and Amanda M. Brandow, DO, MS., Gene Transcription Data Are Correlated with Pain-Related Phenotypic Traits in Individuals with Sickle Cell Disease, American Society of Hematology Annual Meeting, 12/2023
Jimenez Rico, J. Mandip P Kaur, Amanda M Brandow, Ashima Singh, Communication Efforts of Sickle Cell Disease Data Collection Program in Wisconsin [Oral Abstract presentation]., SCDAA, Arlington, Virginia, 2023
Ashima Singh, David C. Brousseau, Mahua Dasgupta, Amanda M. Brandow, Continuity of Acute Care Among Individuals with Sickle Cell Disease Living in Wisconsin, WPHA-WALHDAB Conference Poster Presentation, 05/2024
Alexis Thompson, Ashima Singh, Donna S. Neuberg, Amanda M. Brandow, Allison A. King, Sophie Lanzkron, Emily A. Semmel, Sam Walters, Susan Rogers, Kathleen Hewitt, William A. Wood, Concordance between Investigator-Verified Diagnosis and Manual Data Abstraction for Sickle Cell Diagnosis Type: An ASH Research Collaborative Data Hub Validation, . Poster presentation at American Society of Hematology, 12/2024
Melissa Azul, Janelle Highland, Nicole Steiner, Jessica J. Rico, Hamda Khan, Michelle Brignac, Joshua Field, Jane S Hankins, Ashima Singh, Amanda M. Brandow, Pain-Specific Patient-Reported Outcomes Are Worse in Adults Compared to Children with Sickle Cell Disease, Poster presentation at American Society of Hematology, 12/2024
Samantha N. Atkinson, Katelyn E. Sadler, Janelle Highland, Nicole Steiner, Jessica J. Rico, Dawn Retherford, Jane S Hankins, Hamda Khan, Michelle Brignac, Joshua Field, Ashima Singh, Nita Salzman, Amanda M. Brandow, Individuals with Sickle Cell Disease Have Decreased Intestinal Microbial Diversity Compared to Healthy Related and Unrelated Black Individuals without Sickle Cell Disease, Poster presentation at American Society of Hematology, 12/2024
Ashima Singh, Mahua Dasgupta, Jeffrey Karst, Meghan Miller, Melissa Azul, Amanda M. Brandow, Liliana E Pezzin, Preparing for the Future: Themes in Transition Readiness for Individuals with Sickle Cell Disease Using the ASH Transition Readiness Assessment Tool, Poster presentation at American Society of Hematology, 12/2024
Lana Mucalo, Janelle Highland, Nicole Steiner, Jessica J. Rico, Dawn Retherford, Jane S Hankins, Hamda Khan, Michelle Brignac, Joshua Field, Ashima Singh, Amanda M. Brandow, Comprehensive Assessment of Adequate Nutrition in Children and Adults with Sickle Cell Disease As Determined By Dietary Guidelines for Americans, Poster presentation at American Society of Hematology, 12/2024
 

MCW TEACHING ACTIVITIES:
Medical Student Education
2017 - Present Research Pathway Small Groups for Medical Students (Co-lead), Department of Pediatrics
2023 - Present Research Pathway Small Groups for Medical Students (Co-lead)
 
Resident and Fellow Education
2017 - Present Introduction to Epidemiology, Division of Epidemiology
 

EXTRAMURAL TEACHING:
Graduate Student Education
2013 - Present Graduate School of Public Health, University of Pittsburgh, Epidemiology Methods II (Teaching assistant)
 

OTHER RESEARCH APPOINTMENTS:
2008 - 2009 Graduate Student Assistant, Health Informatics, University of Medicine and Dentistry of New Jersey (now Rutgers)
2010 - 2015 Graduate Researcher, Department of Epidemiology, University of Pittsburgh


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Singh A, Danda V, Van Swol L, Scott, JP, Brandow AM, Panepinto JA. Recommendation to reality: Closing the TCD screening gap for children with sickle cell anemia. Under review at Pediatr Blood Cancer
2. Singh, A., Dasgupta, M., Retherford, D., Fiallo‐Scharer, R., Simpson, P.M. and Panepinto, J.A. Measurement properties of PROMIS domains for children with Type 1 diabetes. Pediatr Diabetes. Accepted Author Manuscript. 2020 Oct
3. Panepinto JA, Brandow A, Mucalo L, Yusuf F, Singh A, Taylor B, et al. Coronavirus disease among persons with sickle cell disease, United States, March 20-May 21, 2020. Emerg Infect Dis. 2020 Oct
4. Nelson A, Singh A, Dasgupta M, Simpson P, Chiu A, Brousseau DC, Panepinto JA. Assessment of pediatric asthma exacerbation with the use of new PROMIS measures. Journal of Asthma. 2020 July.
5. Singh A, Dasgupta M, Simpson PM, Brousseau DC, Panepinto JA. Can PROMIS domains of pain and physical functioning detect changes in health over time for children with sickle cell disease? Pediatr Blood Cancer. Feb 2020
6. Singh A, Panepinto JA. Clinical meaning of PROMIS pain domains for children with sickle cell disease. Blood Adv. 2019 Aug 13;3(15):2244-2249. doi:10.1182/bloodadvances.2019000381.
7. Singh A, Yan K, Brandow AM, Panepinto JA. Longitudinal Trend in Emergency Department Reliance for Pain Among Sickle Cell Disease Patients in Wisconsin. JPediatr Hematol Oncol. 2019 Jun 18. doi: 10.1097/MPH.0000000000001533.
8. Singh A, DasGupta M, Simpson PM, Panepinto JA. Use of the new pediatric PROMIS measures of pain and physical experiences for children with sickle cell disease. Pediatr Blood Cancer. 2019 May;66(5):e27633. doi: 10.1002/pbc.27633.
9. Singh A, Mora J, Panepinto JA. Identification of patients with hemoglobin SS/Sβ(0) thalassemia disease and pain crises within electronic health records. Blood Adv. 2018 Jun 12;2(11):1172-1179. doi: 10.1182/bloodadvances.2018017541.
10. Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, Gourash W, Horlick M, Mitchell JE, Pomp A, Pories WJ, Purnell JQ, Singh A, Spaniolas K, Thirlby R, Wolfe BM, Yanovski SZ. Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Surg. 2018 May 1;153(5):427-434. doi: 10.1001/jamasurg.2017.5025.
11. Singh A, Brooks MM, Voorhees RE, Potter MA, Roberts MS, Luther JF, Wisniewski SR. Cost-Effective Drug Switch Options After Unsuccessful Treatment With an SSRI for Depression. Psychiatr Serv. 2016 Aug 15:appips201500448.
12. Singh A, Schaff HV, Brooks MM, Hlatky MA, Wisniewski SR, Frye RL, Sako EY; BARI 2D Study Group. On-pump versus off-pump coronary artery bypass graft surgery among patients with type 2 diabetes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Eur J Cardiothorac Surg. 2015 May 11.
13. Singh A, Bartsch SM, Muder RR, Lee BY. An Economic Model: Value of Antimicrobial Coated Sutures to Society, Hospitals, and Third Party Payers in Preventing Abdominal Surgical Site Infections. Infect Control Hosp Epidemiol. 2014 Aug;35(8).
14. Lee BY, Wong KF, Bartsch SM, Yilmaz SL, Avery TR, Brown ST, Song Y, Singh A, Kim DS, Huang SS. The Regional Healthcare Ecosystem Analyst (RHEA): a simulation modeling tool to assist infectious disease control in a health system. J Am Med Inform Assoc. 2013 Apr 9.
15. Lee BY, Bartsch SM, Wong KF, Singh A, Avery TR, Kim DS, Brown ST, Murphy CR, Yilmaz SL, Potter MA, Huang SS. The importance of nursing homes in the spread of methicillin resistant Staphylococcus aureus (MRSA) among hospitals. Med Care.2013 Mar; 51(3).
16. Lee BY, Singh A, Bartsch SM, Wong KF, Kim DS, Avery TR, Brown ST, Murphy CR, Yilmaz SL, Huang SS. The potential regional impact of contact precaution use in nursing homes to control methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2013 Feb;34(2).
17. Lee BY, Bartsch SM, Wong KF, Yilmaz SL, Avery TR, Singh A, Song Y, Kim DS, Brown ST, Potter MA, Platt R, Huang SS. Simulation shows hospitals that cooperate on infection control obtain better results than hospitals acting alone. Health Aff (Millwood). 2012 Oct;31(10).
18. Lee BY, Singh A, David MZ, Bartsch SM, Slayton RB, Huang SS, Zimmer SM, Potter MA, Macal CM, Lauderdale DS, Miller LG, Daum RS. The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Clin Microbiol Infect. 2013 Jun;19(6).
19. Lee BY, Song Y, Bartsch SM, Kim DS, Singh A, Avery TR, Brown ST, Yilmaz SL, Wong KF, Potter MA, Burke DS, Platt R, Huang SS. Long-term care facilities: important participants of the acute care facility social network? PLoS One. 2011;6(12).
20. Elie-Turenne MC, Fernandes H, Mediavilla JR, Rosenthal M, Mathema B, Singh A, Cohen TR, Pawar KA, Shahidi H, Kreiswirth BN, Deitch EA. Prevalence and characteristics of Staphylococcus aureus colonization among healthcare professionals in an urban teaching hospital. Infect Control Hosp Epidemiol. 2010 Jun;31(6).
21. Khan H. M. R., Provost S. B. and Singh A. Predictive Inference from a Two-Parameter Rayleigh Life Model Given a Doubly Censored Sample. Communications in Statistics - Theory and Methods, 39(7).
22. Mucalo L, Jia S, Singh A, Roethle M, Panepinto JA, Brousseau DC, Hessner M, Brandow AM. Molecular inflammatory expression profiles associated with the frequency of pain in individuals with sickle cell disease. Blood Adv (in press).
23. Singh A, Szabo A, Lian Q, Pezzin L, Sparapani R, D'Souza A. Timing and co-occurrence of symptoms prior to a diagnosis of light chain (AL) amyloidosis. Blood Cancer J. 2024 May 26;14(1):61. doi: 10.1038/s41408-024-01040-8.
24. Singh A, Brousseau DC, Dasgupta M, Shet AS, Field JJ, Brandow AM. Acute care utilization among individuals with sickle cell disease and related cardiopulmonary and renal complications. PLoS One. 2024 Apr 16;19(4):e0297469. doi: 10.1371/journal.pone.0297469. PMID: 38626063; PMCID: PMC11020686.
25. Kayle M, Blewer AL, Pan W, Rothman JA, Polick CS, Rivenbark J, Fisher E, Reyes C, Strouse JJ, Weeks S, Desai JR, Snyder AB, Zhou M, Sutaria A, Valle J, Horiuchi SS, Sontag MK, Miller JI, Singh A, Dasgupta M, Janson IA, Galadanci N, Reeves SL, Latta K, Hurden I, Cromartie SJ, Plaxco AP, Mukhopadhyay A, Smeltzer MP, Hulihan M. Birth Prevalence of Sickle Cell Disease and County-Level Social Vulnerability - Sickle Cell Data Collection Program, 11 States, 2016-2020. MMWR Morb Mortal Wkly Rep. 2024 Mar 28;73(12):248-254. doi: 10.15585/mmwr.mm7312a1. PMID: 38547025; PMCID: PMC10986820.
26. Phelan R, Aremu TO, Karst J, Anderson L, Jordan A, Morin J, Nichols J, Singh A, Schmidt D, Hoag JA, Napurski C, Zweber H, Sadak KT. Perspectives on Virtual Care for Childhood Cancer Survivors in Non-Metropolitan Areas during the COVID-19 Pandemic. Curr Oncol. 2023 Sep 1;30(9):8111-8116. doi: 10.3390/curroncol30090588. PMID: 37754503; PMCID: PMC10529011.
27. Singh A, Sontag MK, Zhou M, Dasgupta M, Crume T, McLemore M, Galadanci N, Randall E, Steiner N, Brandow AM, Koch K, Field JJ, Hassell K, Snyder AB, Kanter J. Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study. JMIR Public Health Surveill. 2023 Jun 28;9:e42816. doi: 10.2196/42816. PMID: 37379070; PMCID: PMC10365593.
28. Smeltzer MP, Reeves SL, Cooper WO, Attell BK, Strouse JJ, Takemoto CM, Kanter J, Latta K, Plaxco AP, Davis RL, Hatch D, Reyes C, Dombkowski K, Snyder A, Paulukonis S, Singh A, Kayle M. Common data model for sickle cell disease surveillance: considerations and implications. JAMIA Open. 2023 May 27;6(2):ooad036. doi: 10.1093/jamiaopen/ooad036. PMID: 37252051; PMCID: PMC10224800.
29. Mucalo L, Field JJ, Highland J, Khan H, Hankins JS, Singh A, Brandow AM. Preliminary Construct Validity of Patient-Reported Outcomes to Assess Chronic Pain in Adults with Sickle Cell Disease. Blood Adv. 2023 Apr 14:bloodadvances.2023009707. doi: 10.1182/bloodadvances.2023009707.
30. Mason SF, Dasgupta M, Flynn KE, Simpson PM, Singh A. Comparison of CAT and short forms for PROMIS pain and physical health domains in children with sickle cell disease. J Patient Rep Outcomes. 2023 Feb 14;7(1):12. doi: 10.1186/s41687-023-00553-3.
31. Nelson A, Singh A, Dasgupta M, Simpson P, Chiu A, Brousseau DC, Panepinto JA. "Detection of changes of functioning over time after asthma exacerbation in children with the use of PROMIS domains. Journal of Asthma.2021 Sep 27:1-12
32. Singh A, Brandow AM, Panepinto JA. COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals. Blood Adv. 2021 Apr 13;5(7):1915-1921. PMID: 33792626
33. D'Souza A, Pezzin L, Laud P, Singh A. Racial disparities in patients diagnosed with light chain (AL) amyloidosis. Blood Cancer J. 2021 Apr 10;11(4):72. doi: 10.1038/s41408-021-00466-8. PMID: 33839739; PMCID: PMC8036230.
34. Mucalo L, Brandow AM, Dasgupta M, Mason SF, Simpson PM, Singh A, Taylor BW, Woods KJ, Yusuf FI, Panepinto JA. Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease. Blood Adv 2021;5(13): 2717–2724.